Building our first prototypes and replicating existing scientific evidence to validate efficacy and safety for migraine prevention with our own, optimized device.
Large scale randomized clinical trial for our migraine prevention device and optimizing our device for manufacturing and usability.
QMS certification, authority approval for 1st generation professional-use migraine prevention device and clinical trial for 2nd generation at-home device.
Market-launch, roll-out of 1st generation device (professional use) and preparation of G2M with 2nd generation device (at-home).
Our purpose-driven interdisciplinary team brings extensive experience in developing transcranial magnetic stimulation systems from the ground up, mobilizing TMS and bringing it to market, MedTech engineering, regulatory affairs, business development, high performance coil designs, real-time EEG processing and state-of-the-art deep learning technologies.